Prof. Mark A. Wainberg from McGill University AIDS Centre Vi
From November 26 to 27, Prof. Mark A. Wainberg from McGill University AIDS Centre visited School of Pharmaceutical Sciences.
The lecture is titled “Advances in the Use of Antiretroviral Drugs: Where Are We Today?” The postgraduates of medicinal chemistry and immunology attended the lecture. Prof. Wainberg presented the research approach and results of his research group and students asked questions regarding his research, which he answered one by one. After the lecture, he also visited the labs and research centers of medicinal chemistry, companied by Vice dean, Prof. Xinyong Liu.
Dr. Mark A. Wainberg is head of AIDS research at the Lady Davis Institute for Medical Research (LDI), Director of the McGill University AIDS Centre located at the LDI, and Professor of Medicine and of Microbiology and Immunology at McGill University in Montreal. He is an internationally recognized scientist in the field of HIV/AIDS, who served as President of the International AIDS Society between 1998 and 2000 with responsibilities that included organizing the XIIIth International Congress on AIDS in Durban, South Africa in 2000. He was Co-Chair of the XVIth International AIDS Conference that took place in Toronto in 2006. Dr. Wainberg is a member of numerous international advisory committees in the field of AIDS. Among other distinctions, he is a fellow of the Royal Society of Canada, an Officer of the Order of Canada, an officer of the Ordre National du Québec, an honorary fellow of the Royal College of Physicians and Surgeons of Canada, and a Chevalier in the Legion d’Honneur of France. He was the first to identify 3TC as an anti-viral drug effective against HIV in 1989, and has made multiple contributions to the field of HIV drug resistance. His current focus is on novel concepts in preventing HIV infection in developing countries.